Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: CFD RESEARCH CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2021-03-15 to 2023-09-14
Current total value of award: $849874.56
Description: CONDUCT POST MARKETING SAFETY STUDIES AND CLINICAL TRIALS TO ASSES POSSIBLE SERIOUS RISKS ASSICIATED WITH ARTESUNATE FOR INJECTION.